Humacyte Newsroom

Humacyte Is Maintained at Buy by Benchmark

Dow JonesDec 23 22:31

Benchmark Co. Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $17

Futu NewsDec 23 20:31

Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Ligand Pharma (LGND)

TipRanksDec 23 19:54

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 21 03:31

BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 21 02:31

H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $15

Futu NewsDec 21 02:31

BTIG Sticks to Their Buy Rating for Humacyte (HUMA)

TipRanksDec 21 02:22

D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target

BenzingaDec 20 23:21

Humacyte Analyst Ratings

BenzingaDec 20 19:49

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 22 00:31

Promising Clinical Outcomes and Imminent FDA Approval Bolster Buy Rating for Humacyte's Bioengineered Vessel

TipRanksNov 22 00:11

Humacyte Is Maintained at Buy by D. Boral Capital

Dow JonesNov 21 21:06

H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 19 16:39

Humacyte Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow JonesNov 19 01:21

Humacyte Analyst Ratings

BenzingaNov 19 01:12

Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Maintains Target Price $6

Futu NewsNov 14 20:31

H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 13 20:35

Humacyte Is Maintained at Buy by D. Boral Capital

Dow JonesNov 12 06:26

Humacyte Price Target Maintained With a $25.00/Share by D. Boral Capital

Dow JonesNov 12 06:26

Humacyte Analyst Ratings

BenzingaNov 12 06:16